• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC, INC. OPEN PIVOT STANDARD AORTIC HEART VALVE; HEART-VALVE, MECHANICAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC, INC. OPEN PIVOT STANDARD AORTIC HEART VALVE; HEART-VALVE, MECHANICAL Back to Search Results
Model Number 500FA
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Bacterial Infection (1735); Endocarditis (1834); Fever (1858); Pseudoaneurysm (2605); Heart Block (4444)
Event Date 01/01/2017
Event Type  Injury  
Event Description
Medtronic received information via literature regarding a 36-year-old male patient with atopic dermatitis who developed infective endocarditis (ie) due to staphylococcus aureus (s.Aureus) in 2017 and 2020.The patient underwent implant of ats open pivot aortic and mitral mechanical valves, in 2017 and 2020 respectively (unique device identifier numbers not provided).Post-operatively, the patient developed complete atrioventricular (av) block, requiring permanent pacemaker implantation (ppmi).In 2021, the patient presented to the hospital with a persistent high fever.Transthoracic echocardiography (tte) noted ¿a trembling aortic prosthetic valve,¿ computed tomography (ct) detected aortic pseudoaneurysms and blood cultures were again positive for s.Aureus, leading to a new ie diagnosis.The patient underwent surgery to remove the pacemaker leads and replace the mechanical valves with new open pivot aortic/mitral valves (unique device identifier numbers not provided).Intra-operatively, the aortic annulus was noted to be infected with pseudoaneurysms and pledgets sown into the site from the prior surgeries were also infected.The patient was placed on antibiotics, which were continued upon hospital discharge.Post-operative tte and one-year follow-up revealed no issues.No additional adverse patient effects or product performance issues were reported.
 
Manufacturer Narrative
Citation: yajima s.; et al.A novel patch-sparing technique for reconstruction of the aortomitral curtain.Eur j cardiothorac surg 2022; doi:10.1093/ejcts/ezac405.Pmid: (b)(6).Advance access publication 29 july 2022.Medtronic products referenced: ats open pivot (pma# p990046, product code: lwq).Earliest approved product used for product code and pma#.No unique device identifier (serial/lot) numbers were provided; without this information it could not be determined whether these observations have been previously reported.Without return of the product no definitive conclusion can be made regarding the clinical observations.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OPEN PIVOT STANDARD AORTIC HEART VALVE
Type of Device
HEART-VALVE, MECHANICAL
Manufacturer (Section D)
MEDTRONIC, INC.
3800 annapolis lane
minneapolis MN 55447
Manufacturer (Section G)
MEDTRONIC, INC.
3800 annapolis lane
minneapolis MN 55447
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key15974648
MDR Text Key305414629
Report Number3008592544-2022-00081
Device Sequence Number1
Product Code LWQ
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P990046
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 12/13/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/13/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number500FA
Device Catalogue Number500FA
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/16/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
UNKNOWN IPG.
Patient Outcome(s) Life Threatening; Required Intervention; Hospitalization;
Patient Age36 YR
Patient SexMale
Patient RaceAsian
-
-